Innovative Therapies in Ewing Sarcoma

被引:10
|
作者
Teresa Amaral, Ana [1 ]
Luis Ordonez, Jose [1 ]
Pastora Otero-Motta, Ana [1 ]
Garcia-Dominguez, Daniel J. [1 ]
Victoria Sevillano, Maria [1 ]
de Alava, Enrique [1 ,2 ]
机构
[1] Ctr Invest Canc IBSAL CIC, Ctr Invest Canc, Inst Biomed Res Salamanca, Mol Pathol Program, Salamanca, Spain
[2] Hosp Univ Virgen del Rocio IBiS, Dept Pathol, Seville, Spain
关键词
Ewing sarcoma; therapy; clinical trials; animal model; NATURAL-KILLER-CELLS; FACTOR-I-RECEPTOR; HISTONE DEACETYLASE INHIBITORS; GROWTH-FACTOR; HOMOLOGOUS RECOMBINATION; NEDD8-ACTIVATING ENZYME; MONOCLONAL-ANTIBODY; ZOLEDRONIC ACID; PROGNOSTIC IMPACT; TUMOR-GROWTH;
D O I
10.1097/PAP.0000000000000003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.
引用
收藏
页码:44 / 62
页数:19
相关论文
共 50 条
  • [1] Emerging therapies in Ewing sarcoma
    Strauss, Sandra J.
    Berlanga, Pablo
    Mccabe, Martin G.
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (04) : 297 - 304
  • [2] Targeted therapies in Ewing's sarcoma
    Scotlandi, Katia
    NEW TRENDS IN CANCER FOR THE 21ST CENTURY, 2ND EDITION, 2006, 587 : 13 - 22
  • [3] Experimental therapies in Ewing's sarcoma
    Windsor, Rachael
    Strauss, Sandra
    Seddon, Beatrice
    Whelan, Jeremy
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (02) : 143 - 159
  • [4] Signaling pathways and targeted therapies in Ewing sarcoma
    Jia, Ke
    Cao, Li
    Yu, Yihan
    Jing, Doudou
    Wu, Wei
    Van Tine, Brian Andrew
    Shao, Zengwu
    PHARMACOLOGY & THERAPEUTICS, 2025, 266
  • [5] Identifying novel combination therapies for Ewing sarcoma
    Santos, Maria Ana Isabel C. de Los
    Blandin, Anne-Florence
    Aguilar, Alejandra E.
    Hall, Matthew
    Shen, Min
    Zhang, Ya-Qin
    Crompton, Brian D.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Targeted therapies for advanced Ewing sarcoma family of tumors
    Jiang, Yunyun
    Ludwig, Joseph
    Janku, Filip
    CANCER TREATMENT REVIEWS, 2015, 41 (05) : 391 - 400
  • [7] Prospects and challenges for the development of new therapies for Ewing sarcoma
    Grohar, Patrick J.
    Helman, Lee J.
    PHARMACOLOGY & THERAPEUTICS, 2013, 137 (02) : 216 - 224
  • [8] Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board
    Gupta, Ajay
    Dietz, Matthew S.
    Riedel, Richard F.
    Dhir, Aditi
    Borinstein, Scott C.
    Isakoff, Michael S.
    Aye, Jamie M.
    Rainusso, Nino
    Armstrong, Amy E.
    DuBois, Steven G.
    Wagner, Lars M.
    Rosenblum, Jeremy M.
    Cohen-Gogo, Sarah
    Albert, Catherine M.
    Zahler, Stacey
    Chugh, Rashmi
    Trucco, Matteo
    CANCER, 2024, 130 (23) : 4028 - 4039
  • [9] Investigational therapies for Ewing sarcoma: a search without a clear finding
    Vornicova, Olga
    Bar-Sela, Gil
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (06) : 679 - 686
  • [10] Ewing Sarcoma and Ewing-Like Sarcoma
    Yoshida, Akihiko
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S9 - S10